JSPR JASPER THERAPEUTICS, INC.
Research report · from SEC EDGAR · close 2026-07-13
$0.61 +4.9%
$17.0M mkt cap
executive summary
JASPER THERAPEUTICS, INC. (JSPR) is a $17.0M company. It is not yet profitable. Our health score is F (13/100). 2 red flags on file. It may need to raise cash (dilution risk).
⛔Going-concern warning
Auditor flagged substantial doubt about the company continuing for the next 12 months — a raise is usually required.
⚠Active dilution shelf
An effective S-3 shelf with 2 prospectus filing(s) in 12 months — shares may be getting sold into the market.
who's buying
Insider buys / sells
0 / 0
Cash & ST investments
$14.1M
Operating cash flow
-$77.2M
Dilution shelf
active shelf
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-13 by stocktools.ai.